Mo Taha, PhD

Co-Founder at Mojo | Healthcare Angel Investor

πŸ“ United KingdomπŸ”„ Updated September 2026πŸ’Ό 1 investmentsπŸ“… 4 years investingπŸ—“ Last invested Nov 2022
Operator-angel🌍 United Kingdom
1
Total investments
0
Early stage
0
Mid stage
0
Late stage
4y
Years active

Portfolio

1 investments Β· sorted by recency
All investments
Early stage
Mid stage
Late stage
Angel Investor
Nov 2022
Turing Biosystems tackles high failure rates and adverse immune responses to immunotherapy and cell & gene therapy. Our software platform is based on a new kind of interpretable AI that works through automated reasoning. Built on specialized chips, it can integrate any and all modes of clinical/biological data, analyse patient responses to therapies, and design better healthcare interventions. Were here to help both clinicians and biopharma get the right treatments to the right patients at the right time.
Experience Β· 2 entries
All (2)
Investments (1)
Founder (1)
2022
Angel Investor
Nov 2022
Turing Biosystems tackles high failure rates and adverse immune responses to immunotherapy and cell & gene therapy. Our software platform is based on a new kind of interpretable AI that works through automated reasoning. Built on specialized chips, it can integrate any and all modes of clinical/biological data, analyse patient responses to therapies, and design better healthcare interventions. Were here to help both clinicians and biopharma get the right treatments to the right patients at the right time.
2017
Co-Founder
Nov 2017
Mojo Fertility is the world’s first AI-powered digital male fertility clinic. With fertility rates at an all-time low and IVF unaffordable for 95% of people, accessible solutions are urgently needed. 70% of men can improve their fertility with the right support. To address this, Mojo is building an end-to-end, AI-powered digital male fertility clinic that provides clinically validated sperm testing and fertility improvement directly from home β€” giving more couples the best chance to conceive.